首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1673818

微射流市場規模、佔有率及成長分析（按產品、材料、應用、最終用戶和地區）－2025-2032 年產業預測

Microfluidics Market Size, Share, and Growth Analysis, By Product (Microfluidics-based Device, Microfluidic Components), By Material (Glass, Silicon), By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2023 年微射流市場規模將達到 244.8 億美元，從 2024 年的 276.1 億美元成長到 2032 年的 723.7 億美元，預測期內（2025-2032 年）的複合年成長率為 12.8%。

由於慢性病和感染疾病的蔓延以及老齡人口的增加，微射流市場正在迅速擴張。微射流裝置利用微尺度液體和氣體獨特的物理和化學特性，能夠分析較少的樣品和試劑，進而降低應用成本。它廣泛應用於各種過程，包括診斷、癌症篩檢和細胞操作。尤其是製造商正在加強進入新市場，例如uFluidix在熱塑性微射流晶片製造方面的產能擴張和技術創新。總體而言，預計美國微射流市場在未來幾年將持續成長，這反映了該行業的持續發展和市場興趣的日益成長。

市場概覽
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市集活動
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Thermo Fisher Scientific（US）
Becton, Dickinson, and Company（US）
Agilent Technologies（US）
Bio-Rad Laboratories（US）
F. Hoffmann-La Roche（Switzerland）
Danaher Corporation（US）
Illumina Inc.（US）
Fluidigm Corporation（US）
Abbott Laboratories（US）
BioMerieux（France）
Hologic（US）
Quidel Corporation（US）
SMC Corporation（Japan）
Parker-Hannifin Corporation（US）
IDEX Corporation（US）
Fortive Corporation（US）
Aignep SpA（Italy）
Dolomite Microfluidics（UK）
Elveflow（France）
uFluidix（Canada）
NanoString Technologies（US）
Nortis Inc.（US）
Innovative Biochips, LLC（US）
Fluidic Analytics（UK）

結論和建議

簡介目錄

Product Code: SQMIG35A2288

Microfluidics Market size was valued at USD 24.48 billion in 2023 and is poised to grow from USD 27.61 billion in 2024 to USD 72.37 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2025-2032).

The microfluidics market is rapidly expanding, driven by the increasing prevalence of chronic and infectious diseases, as well as the growing elderly population. Microfluidic devices leverage the unique physical and chemical characteristics of liquids and gases at the microscale, allowing for lower application costs by analyzing smaller volumes of samples and reagents. They are widely used in various processes, including diagnostics, cancer screening, and cell manipulation. Notably, manufacturers are intensifying efforts to penetrate new markets, exemplified by uFluidix's recent initiatives to enhance production capacity and innovate in thermoplastic microfluidic chip manufacturing. Overall, the US microfluidics market is projected to experience sustainable growth in the coming years, reflecting the industry's ongoing developments and increasing market interest.

Top-down and bottom-up approaches were used to estimate and validate the size of the Microfluidics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Microfluidics Market Segments Analysis

Global Microfluidics Market is segmented by Product, Material, application, end user and region. Based on Product, the market is segmented into Microfluidics-based Device, Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer, and Others. Based on Application, the market is segmented into In Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics. Based on End User, the market is segmented into Hospital and Diagnostic Centers, Academic and Research Institute, Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Microfluidics Market

The microfluidics market is significantly propelled by innovations in microfluidic technologies, including lab-on-a-chip devices and organ-on-chip systems. These breakthroughs facilitate quicker and more precise diagnostics as well as optimized drug delivery, which are crucial for personalized medicine, point-of-care testing, and pharmaceutical research. As a result, these advancements not only improve healthcare outcomes but also contribute to the overall expansion of the market, responding to the increasing demand for efficient and effective medical solutions. This dynamic growth reflects the ongoing evolution of microfluidics as a vital component in the future of healthcare and life sciences.

Restraints in the Microfluidics Market

One significant constraint hindering the microfluidics market is the lack of awareness and adoption in emerging economies. Many healthcare providers in developing nations are not well-informed about the advantages and uses of microfluidic technologies. This gap in understanding results in slowed integration of these innovative solutions into healthcare systems and contributes to diminished demand for advanced diagnostic and treatment methods. Consequently, the limited penetration of microfluidics in these regions restricts market growth potential and presents challenges for companies seeking to expand their reach and influence in the global healthcare landscape.

Market Trends of the Microfluidics Market

The microfluidics market is witnessing a significant trend towards the increasing demand for point-of-care testing (POC) solutions, driven by the need for rapid and accurate diagnostics. This shift is enhancing patient access to timely healthcare, particularly in remote and rural areas where traditional lab access is limited. The integration of microfluidic technologies in emergency and home healthcare is further fueling this trend, as these devices offer portability, cost-effectiveness, and quick turnaround times for test results. Consequently, the expansion of POC testing is not only transforming patient management strategies but also promoting innovations in microfluidic device design and manufacturing, thereby propelling market growth.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case studies
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Macro-Economic Indicators
PESTEL Analysis
Top Investment Analysis
Key Success Factor
Degree of Competition

Microfluidics Market by Product & CAGR (2025-2032)

Market Overview
Microfluidics-based Device
Microfluidic Components
- Microfluidic Chip
- Flow And Pressure Sensors
- Flow And Pressure Controllers
- Micropumps
- Microfluidic Valves
- Microneedles
- Other Components

Microfluidics Market by Material & CAGR (2025-2032)

Market Overview
Glass
Silicon
Polymer
Others

Microfluidics Market by Application & CAGR (2025-2032)

Market Overview
In Vitro Diagnostics
- Clinical Diagnostics
- Point of Care Testing
- Veterinary Diagnostics
Pharmaceutical & Life Science Research and Manufacturing
- Lab Analytics
- Proteomic analysis
- Genomic analysis
- Cell-based assays
- Capillary electrophoresis
- Microdispensing
- Microreaction
Therapeutics
- Drug Delivery
- Wearable Devices

Microfluidics Market by End-user & CAGR (2025-2032)

Market Overview
Hospital and Diagnostic Centers
Academic and Research Institute
Pharmaceutical & Biotechnology Companies

Microfluidics Market Size & CAGR (2025-2032)

Market Overview
North America (Product, Material, Application, End User)
- US
- Canada
Europe (Product, Material, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Material, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Material, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Material, Application, End User)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Activities in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parker-Hannifin Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEX Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortive Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aignep S.p.A (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dolomite Microfluidics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elveflow (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uFluidix (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nortis Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovative Biochips, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidic Analytics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments